Acadia Pharmaceuticals



Ebit Cambiamento Data
Acadia Pharmaceuticals USD 6.99M 24.66M 2024-12
ALKERMES USD 162.69M 46.46M 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 4.21B 500M 2024-12
Corcept Therapeutics USD 25.26M 20.34M 2024-12
Cytokinetics USD -139040000 1.76M 2024-12
Eisai JPY 18.98B 12.87B 2024-03
Eli Lilly USD 5.63B 3.88B 2024-12
Incyte USD 376.26M 121.03M 2024-12
Intra Cellular Therapies USD -29197000 9.65M 2024-12
J&J USD 5.35B 1.14B 2024-12
Moderna USD -1246000000 1.18B 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Prothena USD -64897000 1.62M 2024-12
PTC Therapeutics USD -162389000 107.88M 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Acadia Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.